SRC Promotes Tamoxifen Resistance in Breast Cancer via Up-Regulating SIRT1

BACKGROUND: Endocrine therapy plays a key role in estrogen receptor-positive breast cancer patients; but, tamoxifen resistance could be a real difficulty for these patients. Several attempts have been made to explore the mechanism and new therapies for these patients. We intend to clarify the expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jun, Xu, Ming, Le, Kehao, Ming, Jie, Guo, Hui, Ruan, Shengnan, Huang, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259490/
https://www.ncbi.nlm.nih.gov/pubmed/32547094
http://dx.doi.org/10.2147/OTT.S245749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259490/
https://www.ncbi.nlm.nih.gov/pubmed/32547094
http://dx.doi.org/10.2147/OTT.S245749

Ejemplares similares